Bellevue Asset Management’s Teva Pharmaceuticals TEVA Stock Holding History

Bellevue Asset Management’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$6.78K	Hold	200	–	–	﹤0.01%	326
2026 Q1	$6.02K	Hold	200	–	–	﹤0.01%	312
2025 Q4	$6.24K	Hold	200	–	–	﹤0.01%	319
2025 Q3	$4.04K	Hold	200	–	–	﹤0.01%	365
2025 Q2	$3.35K	Hold	200	–	–	﹤0.01%	391
2025 Q1	$3.07K	Hold	200	–	–	﹤0.01%	384
2024 Q4	$4.41K	Hold	200	–	–	﹤0.01%	361
2024 Q3	$3.6K	Hold	200	–	–	﹤0.01%	351
2024 Q2	$3.25K	Hold	200	–	–	﹤0.01%	358
2024 Q1	$2.82K	Hold	200	–	–	﹤0.01%	376
2023 Q4	$2.09K	Hold	200	–	–	﹤0.01%	402
2023 Q3	$2.04K	Hold	200	–	–	﹤0.01%	383
2023 Q2	$1.51K	Hold	200	–	–	﹤0.01%	438
2023 Q1	$1.77K	Hold	200	–	–	﹤0.01%	426
2022 Q4	$1.81K	Hold	200	–	–	﹤0.01%	413
2022 Q3	$2K	Hold	200	–	–	﹤0.01%	433
2022 Q2	$2K	Hold	200	–	–	﹤0.01%	437
2022 Q1	$2K	Hold	200	–	–	﹤0.01%	477
2021 Q4	$2K	Hold	200	–	–	﹤0.01%	518
2021 Q3	$2K	Hold	200	–	–	﹤0.01%	541
2021 Q2	$2K	Hold	200	–	–	﹤0.01%	544
2021 Q1	$2K	Hold	200	–	–	﹤0.01%	601
2020 Q4	$2K	Sell	200 -200	-50%	-$1.92K	﹤0.01%	608
2020 Q3	$4K	Hold	400	–	–	﹤0.01%	454
2020 Q2	$5K	Hold	400	–	–	0.01%	405
2020 Q1	$4K	Hold	400	–	–	﹤0.01%	429
2019 Q4	$4K	Buy	+400	New	+$3.57K	﹤0.01%	372

Other funds holding TEVA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

HIIFS

Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return

Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return

MMH

Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return

MIFH

Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

LIM

Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

Bellevue Asset Management's TEVA Position: Q2 2026 in Review

Bellevue Asset Management held its Teva Pharmaceuticals (TEVA) position steady in Q2 2026 at 200 shares worth $6.78K. The position accounts for ﹤0.01% of the portfolio, ranked #326.

Bellevue Asset Management first reported a position in TEVA in Q4 2019 and has held it in 27 quarters since. 672 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

Bellevue Asset Management held 200 shares of Teva Pharmaceuticals worth $6.78K as of Q2 2026.
Bellevue Asset Management left its Teva Pharmaceuticals share count unchanged in Q2 2026.
Teva Pharmaceuticals made up ﹤0.01% of Bellevue Asset Management's portfolio in Q2 2026, its #326 holding.
Bellevue Asset Management first reported a position in Teva Pharmaceuticals in Q4 2019 and has held it in 27 quarters since.
672 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2026.

Based on Bellevue Asset Management's 13F filing for Q2 2026, filed 4 Aug 2026.